Korean Journal of Ophthalmology10.3341/kjo.2016.01252017315424Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical ExperienceAbdullah Ozkaya, Zeynep Alkin, Mesut Togac, Sibel Ahmet, Irfan Perente, Muhittin Taskapili,,
Clinical Ophthalmology10.2147/opth.s1468420101271Initial clinical experience of ranibizumab therapy for neovascular age-related macular degenerationTryfon Rotsos, patel
Journal of Clinical Medicine10.3390/jcm10122666202110122666Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month OutcomesChristof Haensli, Isabel B. Pfister, Justus G. Garweg
Clinical Ophthalmology10.2147/opth.s102592010913Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases Vemala
Clinical Ophthalmology10.2147/opth.s4938520131849Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS studyIvo Abraham, Rakic, Anita Leys, Brie, Denhaerynck, Pacheco, Vancayzeele, Hermans, Karen MacDonald
Clinical Ophthalmology10.2147/opth.s10105020161047Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-upNadezhda Cvetkova, Kristina Hoelldobler, Philipp Prahs, Viola Radeck, Horst Helbig, David Maerker
Clinical Ophthalmology10.2147/opth.s2183782019Volume 132461-2467<p>Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)</p>Faye Horner, Peck Lin Lip, Hannah Clark, Randhir Chavan, Ambreen Sarmad, Bushra Mushtaq,
Ophthalmology10.1016/j.ophtha.2016.05.05420171243e31-e32Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761)Mark C. Gillies, Vincent Daien, Vuong Nguyen, Daniel Barthelmes,
Clinical Ophthalmology10.2147/opth.s2691622021Volume 15279-287Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular DegenerationMuhammad Raza Cheema, Joanna DaCosta, James Talks,
Clinical Ophthalmology10.2147/opth.s92627201687A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in&nbsp;the UKSobha Sivaprasad, Philip Hykin, Usha Chakravarthy, Andrew Lotery, Martin McKibbin, Jackie Napier